This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Rensselaer Polytechnic Institute, The Board of Regents of the University of Nebraska, The University of North Carolina at Chapel Hill. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2018
Title: The Innovations of Edward Harris
Introduction
Edward Harris is a notable inventor based in Lincoln, NE (US). He has made significant contributions to the field of biomedical research, particularly in the development of heparin compounds. His work focuses on creating innovative methods for synthesizing low molecular weight heparins with reversible anticoagulant activity.
Latest Patents
Harris holds a patent for "Reversible heparin molecules and methods of making and using the same." This patent outlines methods and systems for synthesizing heparin compounds. The chemoenzymatic synthesis of structurally homogeneous low molecular weight heparins that exhibit reversible anticoagulant activity is a key feature of this invention. The patent also describes heparin compounds that possess anticoagulant activity, including a binding affinity to antithrombin and anti-Xa activity, while showing no detectable anti-lla activity. Additionally, the invention provides synthetic, low-molecular weight heparin compounds with reversible anticoagulant activity, which can be reversed by protamine.
Career Highlights
Throughout his career, Edward Harris has worked at prestigious institutions such as the University of North Carolina at Chapel Hill and Rensselaer Polytechnic Institute. His research has significantly advanced the understanding and application of heparin in medical treatments.
Collaborations
Harris has collaborated with esteemed colleagues, including Robert J. Linhardt and Jian Liu. These partnerships have further enriched his research and contributed to the development of innovative heparin compounds.
Conclusion
Edward Harris is a pioneering inventor whose work in reversible heparin molecules has the potential to transform anticoagulant therapies. His contributions to the field are invaluable and continue to influence biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile